Your browser doesn't support javascript.
loading
Integration of Antiangiogenic Therapy with Cisplatin and Gemcitabine Chemotherapy in Patients with Nasopharyngeal Carcinoma.
Chong, Wan Qin; Lim, Chwee Ming; Sinha, Arvind Kumar; Tan, Chee Seng; Chan, Gloria Hui Jia; Huang, Yiqing; Kumarakulasinghe, Nesaretnam Barr; Sundar, Raghav; Jeyasekharan, Anand D; Loh, Woei Shyang; Tay, Joshua K; Yadav, Kritika; Wang, Lingzhi; Wong, Andrea L; Kong, Li Ren; Soo, Ross Andrew; Lau, Jieying Amelia; Soon, Yu Yang; Goh, Robby Miguel; Ho, Francis Cho Hao; Chong, Siew Meng; Lee, Soo Chin; Loh, Kwok Seng; Tai, Bee Choo; Lim, Yaw Chyn; Goh, Boon Cher.
Afiliação
  • Chong WQ; Department of Haematology-Oncology, National University Cancer Institute, Singapore.
  • Lim CM; Department of Otolaryngology - Head and Neck Surgery, National University of Singapore, Singapore.
  • Sinha AK; Department of Diagnostic Imaging, National University Health System, Singapore.
  • Tan CS; Department of Haematology-Oncology, National University Cancer Institute, Singapore.
  • Chan GHJ; Department of Haematology-Oncology, National University Cancer Institute, Singapore.
  • Huang Y; Department of Haematology-Oncology, National University Cancer Institute, Singapore.
  • Kumarakulasinghe NB; Department of Haematology-Oncology, National University Cancer Institute, Singapore.
  • Sundar R; Department of Haematology-Oncology, National University Cancer Institute, Singapore.
  • Jeyasekharan AD; Department of Haematology-Oncology, National University Cancer Institute, Singapore.
  • Loh WS; Cancer Science Institute of Singapore, NUS, Singapore.
  • Tay JK; Department of Otolaryngology - Head and Neck Surgery, National University of Singapore, Singapore.
  • Yadav K; Department of Otolaryngology - Head and Neck Surgery, National University of Singapore, Singapore.
  • Wang L; Cancer Science Institute of Singapore, NUS, Singapore.
  • Wong AL; Cancer Science Institute of Singapore, NUS, Singapore.
  • Kong LR; Department of Pharmacology, National University of Singapore, Singapore.
  • Soo RA; Department of Haematology-Oncology, National University Cancer Institute, Singapore.
  • Lau JA; Cancer Science Institute of Singapore, NUS, Singapore.
  • Soon YY; Cancer Science Institute of Singapore, NUS, Singapore.
  • Goh RM; Department of Haematology-Oncology, National University Cancer Institute, Singapore.
  • Ho FCH; Cancer Science Institute of Singapore, NUS, Singapore.
  • Chong SM; Cancer Science Institute of Singapore, NUS, Singapore.
  • Lee SC; Department of Radiation Oncology, National University Cancer Institute, Singapore.
  • Loh KS; Department of Haematology-Oncology, National University Cancer Institute, Singapore.
  • Tai BC; Department of Radiation Oncology, National University Cancer Institute, Singapore.
  • Lim YC; Department of Pathology, National University of Singapore, Singapore.
  • Goh BC; Department of Haematology-Oncology, National University Cancer Institute, Singapore.
Clin Cancer Res ; 26(20): 5320-5328, 2020 10 15.
Article em En | MEDLINE | ID: mdl-32816944

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cisplatino / Desoxicitidina / Carcinoma Nasofaríngeo / Neovascularização Patológica Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cisplatino / Desoxicitidina / Carcinoma Nasofaríngeo / Neovascularização Patológica Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article